ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Natural History and Genetic Studies of Usher Syndrome

This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), October 2007

Sponsored by: National Eye Institute (NEI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00106743
  Purpose

This study will explore clinical and genetic aspects of Usher syndrome, an inherited disease causing deafness or impaired hearing, visual problems, and, in some cases, unsteadiness or balance problems. Patients with type 1 Usher syndrome usually are deaf from birth and have speech and balance problems. Patients with type 2 disease generally are hearing impaired but have no balance problems. Patients with type 3 disease have progressive hearing loss and balance problems. All patients develop retinitis pigmentosa, an eye disease that causes poor night vision and eventually, blindness.

Patients of any age with Usher syndrome may be eligible for this study. Patients who have had eye and hearing evaluations are asked to send their medical records to the research team at the National Eye Institute (NEI) for review. They are also asked to have a blood sample drawn by a medical professional and sent to NEI for genetic analysis. Finally, they are interviewed about their family histories, particularly about other relative with eye disease. Patients who have not been evaluated previously have the following tests and procedures at NIH:

  • Family medical history, especially regarding eye disease. A family tree is drawn.
  • Blood draw for genetic studies of Usher syndrome.
  • Eye examination to assess visual acuity and eye pressure, and to examine pupils, lens, retina, and eye movements.
  • Electroretinogram (ERG) to test the function of visual cells. Wearing eye patches, the patient sits in a dark room for 30 minutes. Electrodes are taped to the forehead and the eye patches are removed. The surface of the eye is numbed with eye drops and contact lenses are placed on the eyes. The patient looks inside a hollow, dark globe and sees a series of light flashes. Then a light is turned on inside the globe and more flashes appear. The contact lenses sense small electrical signals generated by the retina when the light flashes.
  • Fluorescein angiography to evaluate the eye's blood vessels. A yellow dye is injected into an arm vein and travels to the blood vessels in the eyes. Pictures of the retina are taken using a camera that flashes a blue light into the eye. The pictures show if any dye has leaked from the vessels into the retina, indicating possible blood vessel abnormality.
  • Hearing tests to help determine the patient's type of Usher syndrome. Tests to evaluate hearing include examination of both ears with an otoscope, evaluation of the middle ear and inner ...

Condition
Retinitis Pigmentosa Syndromic
Congenital Deafness
Usher Syndrome
Retinitis Pigmentosa and Deafness
Progressive Hearing Loss
Retinitis Pigmentosa

Genetics Home Reference related topics:   Lenz microphthalmia syndrome    nonsyndromic deafness    oculofaciocardiodental syndrome    Peters plus syndrome    Usher syndrome    X-linked juvenile retinoschisis   

MedlinePlus related topics:   Eye Diseases    Hearing Disorders and Deafness    Usher Syndrome   

U.S. FDA Resources

Study Type:   Observational
Official Title:   Natural History and Genetic Studies of Usher Syndrome

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:   400
Study Start Date:   March 2005

Show detailed description  Show Detailed Description

  Eligibility
Ages Eligible for Study:   2 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria
  • INCLUSION CRITERIA:

The patients must have documentation of neurosensory hearing loss and retinitis pigmentosa and fulfill the clinical characteristics for USH1, USH2 as defined by the Usher syndrome consortium (Smith RJ, Berlin CI, Hejtmancik JF, Keats BJ, Kimberling WJ, Lewis RA, Moller CG, Pelias MZ, Tranebjaerg L. Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium. Am J Med Genet. 1994 Mar 1;50(1):32-8). Patients with documented presence of retinitis pigmentosa, severe to profound hearing loss and absent vestibular responses will be categorized as Usher type I. Patients with documented presence of retinitis pigmentosa, moderate to severe hearing loss and normal vestibular responses will be categorized as Usher type II. Patients with documented presence of retinitis pigmentosa, progressive hearing loss and variable vestibular responses will be categorized as Usher type III.

EXCLUSION CRITERIA:

Intrauterine and childhood infections, and intrauterine and birth complications can result in trauma to both the auditory or visual system and a positive history for these conditions will necessitate exclusion from the study. Patients with concurrent inherited or acquired conditions that significantly affect the visual and/or auditory system and significantly alter the phenotype will be excluded. Also patients unwilling to provide a blood sample or unable to undergo the study procedures will be excluded from the study.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00106743

Contacts
Contact: Patient Recruitment and Public Liaison Office     (800) 411-1222     prpl@mail.cc.nih.gov    
Contact: TTY     1-866-411-1010    

Locations
United States, Maryland
National Eye Institute (NEI), 9000 Rockville Pike     Recruiting
      Bethesda, Maryland, United States, 20892
Israel
Bnai Zion Medical Center     Recruiting
      Haifa, Israel

Sponsors and Collaborators
  More Information


NIH Clinical Center Detailed Web Page  This link exits the ClinicalTrials.gov site
 

Publications:

Study ID Numbers:   050096, 05-EI-0096
First Received:   March 29, 2005
Last Updated:   July 18, 2008
ClinicalTrials.gov Identifier:   NCT00106743
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Retnitis Pigmentosa Syndromic  
Congenital Deafness  
Usher Syndrome  
Retinitas Pigmentosa and Deafness  
Progressive Hearing Loss
Usher Syndrome
Retinitis Pigmentosa
Congenital Deafness

Study placed in the following topic categories:
Sensation Disorders
Vision Disorders
Sensorineural hearing loss
Retinitis
Hearing Loss, Sensorineural
Ear Diseases
Usher Syndromes
Pigmentary retinopathy
Signs and Symptoms
Hearing Disorders
Deafness
Retinitis Pigmentosa
Cone rod dystrophy
Abnormalities, Multiple
Eye Diseases, Hereditary
Hearing Loss
Congenital Abnormalities
Retinal Diseases
Retinitis pigmentosa-deafness syndrome
Otorhinolaryngologic Diseases
Eye Diseases
Retinal Degeneration
Blindness
Congenital deafness
Genetic Diseases, Inborn
Hereditary deafness
Neurologic Manifestations
Usher syndrome
Retinal degeneration

Additional relevant MeSH terms:
Pathologic Processes
Disease
Syndrome
Nervous System Diseases
Deaf-Blind Disorders

ClinicalTrials.gov processed this record on September 23, 2008




Links to all studies - primarily for crawlers